When Sarah was diagnosed with endometriosis at age 22, the words felt like a death sentence. Her gynecologist, Dr. Patterson, sat her down with a grim expression and said: “Sarah, I won’t sugar-coat this. The severity of your condition—with the extensive scarring and inflammation—makes pregnancy extremely unlikely without aggressive intervention. Even then, success rates are below 10%.”
Sarah’s dreams of motherhood felt like they were slipping away before her life had even truly begun. She spent three years trying various treatments—hormone therapies, laparoscopic surgeries, special diets. Nothing worked. She watched her friends get pregnant, attend baby showers, and felt increasingly isolated. She even considered adoption, though the process felt like accepting defeat.
At 28, Sarah decided to try one final IVF cycle with an experimental approach: a new pre-implantation genetic screening combined with a specialized uterine preparation protocol. She was told her chances were still only 15%. She went into the procedure expecting nothing, preparing herself emotionally for another disappointment.
But something changed. The embryo took. The pregnancy progressed. At 9 months, doctors induced labor out of caution. And then, on a rainy Thursday in April, her daughter Emma entered the world. Sarah held her baby and couldn’t stop crying—tears of disbelief, gratitude, and triumph.
Now Sarah speaks to other women with endometriosis, telling them that their diagnosis is not their destiny. She volunteers with a fertility advocacy group and has helped dozens of women access the experimental treatments that saved her dream.